160 related articles for article (PubMed ID: 35893136)
21. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
22. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.
Litvintseva AP; Lindsley MD; Gade L; Smith R; Chiller T; Lyons JL; Thakur KT; Zhang SX; Grgurich DE; Kerkering TM; Brandt ME; Park BJ
Clin Infect Dis; 2014 Mar; 58(5):622-30. PubMed ID: 24336827
[TBL] [Abstract][Full Text] [Related]
23. Screening Coccidioides serology in kidney transplant recipients: A 10-year cross-sectional analysis.
Phonphok K; Beaird O; Duong T; Datta N; Schaenman J; Bunnapradist S
Transpl Infect Dis; 2018 Oct; 20(5):e12932. PubMed ID: 29809303
[TBL] [Abstract][Full Text] [Related]
24. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive
Forster J; Koc Ö; Koeppel MB; Hamprecht A; Kurzai O; Suerbaum S; Wagener J; Dichtl K
J Clin Microbiol; 2022 Jan; 60(1):e0160721. PubMed ID: 34669454
[No Abstract] [Full Text] [Related]
25. Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation.
Mendoza N; Noel P; Blair JE
Transpl Infect Dis; 2015 Jun; 17(3):380-8. PubMed ID: 25682795
[TBL] [Abstract][Full Text] [Related]
26. Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis.
McHardy IH; Barker B; Thompson GR
J Clin Microbiol; 2023 May; 61(5):e0158122. PubMed ID: 36883820
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a commercially available, point-of-care Coccidioides antibody lateral flow assay to aid in rapid diagnosis of coccidioidomycosis in dogs.
Schlacks S; Vishkautsan P; Butkiewicz C; Shubitz L
Med Mycol; 2020 Apr; 58(3):328-332. PubMed ID: 31212311
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of Serologic Testing for Dogs Diagnosed with Coccidioidomycosis on Histology: 52 Cases (2012-2013).
Gunstra A; Steurer JA; Seibert RL; Dixon BC; Russell DS
J Am Anim Hosp Assoc; 2019; 55(5):238-242. PubMed ID: 31433229
[No Abstract] [Full Text] [Related]
29. Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data.
Ferreras-Antolin L; Borman A; Diederichs A; Warris A; Lehrnbecher T
J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547595
[TBL] [Abstract][Full Text] [Related]
30. Concomitant Central Nervous System Toxoplasmosis and Seronegative Disseminated Coccidioidomycosis in a Newly Diagnosed Acquired Immune Deficiency Syndrome Patient.
Valdez M; Moosavi L; Heidari A
J Investig Med High Impact Case Rep; 2019; 7():2324709619869372. PubMed ID: 31423835
[TBL] [Abstract][Full Text] [Related]
31. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers in the epidemiology and diagnosis of coccidioidomycosis.
Duarte-Escalante E; Frías-De-León MG; Zúñiga G; Martínez-Herrera E; Acosta-Altamirano G; Reyes-Montes Mdel R
Rev Iberoam Micol; 2014; 31(1):49-53. PubMed ID: 24270069
[TBL] [Abstract][Full Text] [Related]
33. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts.
Blair JE; Coakley B; Santelli AC; Hentz JG; Wengenack NL
Mycopathologia; 2006 Nov; 162(5):317-24. PubMed ID: 17123029
[TBL] [Abstract][Full Text] [Related]
34. (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs).
Fontana C; Gaziano R; Favaro M; Casalinuovo Ia; Pistoia E; Di Francesco P
Open Microbiol J; 2012; 6():70-3. PubMed ID: 22942923
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
36. PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona.
Kollath DR; Mihaljevic JR; Barker BM
Microbiol Spectr; 2022 Apr; 10(2):e0148321. PubMed ID: 35319247
[TBL] [Abstract][Full Text] [Related]
37. Dectin-1 is required for resistance to coccidioidomycosis in mice.
Viriyakosol S; Jimenez Mdel P; Gurney MA; Ashbaugh ME; Fierer J
mBio; 2013 Feb; 4(1):e00597-12. PubMed ID: 23386437
[TBL] [Abstract][Full Text] [Related]
38. (1→3)-β-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients.
Salvatore CM; Chen TK; Toussi SS; DeLaMora P; Petraitiene R; Finkelman MA; Walsh TJ
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):277-86. PubMed ID: 26407252
[TBL] [Abstract][Full Text] [Related]
39. Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis.
Williams SL; Chiller T
J Fungi (Basel); 2022 Jun; 8(7):. PubMed ID: 35887423
[TBL] [Abstract][Full Text] [Related]
40. Multicenter Clinical Validation of a Cartridge-Based Real-Time PCR System for Detection of Coccidioides spp. in Lower Respiratory Specimens.
Saubolle MA; Wojack BR; Wertheimer AM; Fuayagem AZ; Young S; Koeneman BA
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29212702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
